Back

Lipoprotein(a) levels in patients hospitalized for acute coronary syndrome according to prior statin therapy.

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Clinical impact of lipid‑lowering strategies Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Antonio Meseguer Hernandez

General University Hospital Santa Lucia, Cartagena (Spain)

7 More presentations in this session

Presentation thumbnail
Efficacy and safety of recaticimab in lowering atherogenic lipids in patients with and without coronary artery disease: a patient-level pooled analysis
Professor C. Li (Nanjing, CN)
Abstract Slides
Presentation thumbnail
Comparative efficacy of APOC3- and ANGPTL3-targeted therapies in severe hypertriglyceridemia: a systematic review and network meta-analysis
Doctor G. Caldeira Gaelzer (Curitiba, BR)
Abstract Slides
Presentation thumbnail
Quantitative and qualitative lipid responses to lipid-lowering therapy and cardiovascular outcomes after percutaneous coronary intervention for acute myocardial infarction
Doctor K. Lee (Daejeon, KR)
Presentation thumbnail
Design and baseline data of AZURE-LDL, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with, or at risk for, ASCVD
Doctor M. Koren (Jacksonville, US)
Abstract Slides
Presentation thumbnail
Treatment with PCSK9 inhibitors reduces the expression of scavenger receptors CD16, CD36 and CD45 in patients with stable coronary artery disease and elevated Lp(a) levels
Doctor S. Ugovsek (Ljubljana, SI)
Abstract Slides

Access the full session

Session thumbnail
Clinical impact of lipid‑lowering strategies

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin
27 August 2021
thumbnail
Congress Presentation
Statin adherence in coronary outpatients: a novel direct method compared with pharmacy registry data
26 April 2024
thumbnail
Congress Presentation
The association between lipoprotein (a) levels and body composition
4 April 2025
thumbnail
Congress Presentation
Characteristics of patients with a lipoprotein(a) assessment - a health insurance claims database analysis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources